Related Experiment Video

Updated: Aug 18, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression

Young Mi Whang1, Yeul Hong Kim, Jun Suk Kim

  • 1Department of Internal Medicine and Brain Korea 21 Project for Biomedical Science, Korea University Cancer Institute, Seoul, South Korea.

Cancer Research
|May 4, 2005
PubMed

Insights

The tumor suppressor RASSF1A inhibits lung cancer cell growth by blocking the c-Jun-NH2-kinase (JNK) pathway. This study demonstrates RASSF1A

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Oncogenes like Ras drive malignant transformation in lung cells.
  • Activation of c-Jun-NH2-kinase (JNK) is critical for oncogenic functions in lung cancer.

Purpose of the Study:

  • To investigate the role of RASSF1A in inhibiting lung cancer cell growth.
  • To determine if RASSF1A blocks the JNK pathway in lung cancer cells.

Main Methods:

  • Exogenous expression of RASSF1A in lung cancer cells.
  • Western blot analysis to assess JNK and c-Jun phosphorylation and Cyclin D1 levels.
  • In vitro kinase assays to measure JNK activity.
  • RNA interference (siRNA) to confirm RASSF1A's effect.

Main Results:

  • Exogenous RASSF1A expression suppressed JNK phosphorylation.
  • Stable RASSF1A transfection led to reduced JNK and c-Jun phosphorylation and Cyclin D1 downregulation.
  • RASSF1A inhibited JNK activity in vitro.
  • siRNA treatment reversed the JNK activity suppression caused by RASSF1A.

Conclusions:

  • RASSF1A acts as a tumor suppressor in lung cells.
  • RASSF1A inhibits lung cancer cell growth by blocking oncogene-mediated JNK activation.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...